Location History:
- Brookline, MA (US) (2013)
- Montreal, CA (2017)
Company Filing History:
2 out of 40 
1 out of 2,405 
Years Active: 2013-2017
Title: The Innovations of Daniel Simard
Introduction
Daniel Simard is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical health issues such as HIV and asthma. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
One of Simard's latest patents focuses on HIV protease inhibitors. This invention is directed to 5-heteroarylmorpholine derivatives and their use in inhibiting HIV protease, thereby preventing HIV replication and treating infections. The compounds can be utilized in pharmaceutical compositions, potentially in combination with other antivirals, immunomodulators, antibiotics, or vaccines. Another significant patent involves azaindole derivatives as CRTH2 receptor antagonists. These compounds are antagonists of the PGD2 receptor, CRTH2, and are useful in treating and preventing CRTH2-mediated diseases such as asthma.
Career Highlights
Throughout his career, Daniel Simard has worked with prominent companies in the pharmaceutical industry, including Merck Canada Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas.
Collaborations
Simard has collaborated with several professionals in his field, including Yves Leblanc and Carl Berthelette. These partnerships have likely contributed to the success of his inventions and patents.
Conclusion
Daniel Simard's contributions to pharmaceutical innovations demonstrate his commitment to addressing critical health challenges. His patents in HIV treatment and asthma prevention highlight the importance of research and development in improving public health.